As of November 10, 2026, Iambic Therapeutics, Inc. is a publicly traded company (Nasdaq: IAM); its largest reported holder is Qatar Investment Authority, with 5.8% on Schedule 13G of November 9, 2026. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13G, November 9, 2026).
Is this your company?
About to sign with, pay or invest in Iambic Therapeutics, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Iambic Therapeutics, Inc. a real, registered company?
- Iambic Therapeutics, Inc. files with the SEC under CIK 1997038 (its SEC filings).
- Its first SEC filing on record is dated 2023-10-12 (SEC filings).
- Its shares are listed under the ticker IAM on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in San Diego, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Iambic Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-11-10).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Qatar Investment Authority (filed 2026-11-09).
Who are Iambic Therapeutics, Inc.'s owners and officers?
Iambic Therapeutics, Inc.: incorporated in Delaware; business address in San Diego, California; industry Biological Products, (No Diagnostic Substances) (Schedule 13G, 2026-11-09).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2026-09-09)
- : Executive Officer, Director (Form D, 2026-09-09)
- : Executive Officer (Form D, 2026-09-09)
- : Executive Officer (Form D, 2026-09-09)
- : Director (Form D, 2026-09-09)
- : Director (Form D, 2026-09-09)
- : Director (Form D, 2026-09-09)
- : Director (Form D, 2026-09-09)
- : Director (Form D, 2026-09-09)
- : Director (Form D, 2026-09-09)
- : Director (Form D, 2026-09-09)
- : Executive Officer (Form D, 2026-09-09)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-11-09 | Qatar Investment Authority | 5.8% |
Want the whole picture on Iambic Therapeutics, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Iambic Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Iambic Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
How much has Iambic Therapeutics, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-09-09 | $65.97M | $66.50M |
| Form D, 2026-04-08 | $27.77M | $50M |
| Form D, 2025-11-21 | $99.27M | $125M |
| Form D, 2024-04-25 | $26.87M | $38M |
| Form D, 2023-10-12 | $103.23M | $110M |
Latest IPO step: Iambic Therapeutics, Inc. filed its final IPO prospectus, ticker IAM (424B4, 2026-10-15).
IPO filings: 424B4, 2026-10-15, S-1/A, 2026-10-08, S-1, 2026-09-21; ticker IAM on Nasdaq Global Select Market.
Keep reading
More on Iambic Therapeutics, Inc. and the records around it.
The people at Iambic Therapeutics, Inc.
- William Rastetter is also named on 6 other Form D filings: Dare Bioscience, Inc. (Aug 2026)
Iambic Therapeutics, Inc. elsewhere on the record
- IPO filing Oct 2026
- Company profile and every filing Sep 2026
- Form D filing Sep 2026
- Form D filing Apr 2026
Companies that share a holder
- Qatar Investment Authority also filed stake reports on 11 other companies: Aspen Neuroscience, Inc. (Nov 2026), Global Business Travel Group, Inc. (Sep 2026), Nanobiotix SA (Jul 2026)
Related pages
Funding and filing historyIPO filings
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/iambic-therapeutics-inc